| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/07/1993 | EP0549686A1 Modified internucleoside linkages |
| 07/07/1993 | EP0549668A1 Anti-hypertensive tetralins |
| 07/07/1993 | EP0549660A1 Enhancement of glutathione levels with glutamine |
| 07/07/1993 | EP0549621A1 New leukotriene-b 4? antagonists, process for producing the same and their use as medicinal drugs. |
| 07/07/1993 | EP0549615A1 Sugar modified oligonucleotides that detect and modulate gene expression |
| 07/07/1993 | EP0549606A1 Composition containing silver sulfadiazine and benzocaine for use in the treatment of wounds following laser surgery |
| 07/07/1993 | EP0549600A1 5-trifluoroacylamino-2-aryl oxazoles |
| 07/07/1993 | EP0549598A1 2-METHYLIMIDAZO[4,5-c]PYRIDINE DERIVATIVES AND THERAPEUTIC AGENTS |
| 07/07/1993 | EP0549597A1 Anionic furanose derivatives, methods of making and using the same |
| 07/07/1993 | EP0549592A1 Stabilized retinoid-containing skin care compositions |
| 07/07/1993 | EP0538330A4 Beta-alethine use in cell culture and therapy |
| 07/07/1993 | EP0536255A4 Ophthalmic suspensions |
| 07/07/1993 | EP0469007B1 Preparation for care of nails, skin and hair |
| 07/07/1993 | EP0412110B1 Novel vitamin d analogues |
| 07/07/1993 | CN1073948A Indolopyrrolocarbazole derivatives |
| 07/07/1993 | CN1073944A Tri-substituted tetrahydrofuran antifungals |
| 07/07/1993 | CN1073942A Heterocycle-substituted benzenemethanamine derivatives |
| 07/07/1993 | CN1073936A Alpha-substituted benzenemethanamine derivatives |
| 07/07/1993 | CN1073861A Medicinal composite to improve dysuria |
| 07/07/1993 | CN1073859A Compositions for regulating skin wrinkles and/or skin atrophy |
| 07/07/1993 | CA2086698A1 Pyridylsulfonylurea derivatives, processes for their preparation and pharmaceutical compositions containing them |
| 07/07/1993 | CA2058817A1 Pharmaceutical preparation for topical application |
| 07/06/1993 | US5225585 Antidepressants |
| 07/06/1993 | US5225566 Smooth muscle relaxants; hypotensive agents; potassium channel activators |
| 07/06/1993 | US5225559 Diarylmethoxypiperidine derivatives |
| 07/06/1993 | US5225558 2-amino-5-cyano-1,4-dihydropyridines, and their use in medicaments |
| 07/06/1993 | US5225550 Process for the preparation of substituted acyclic nucleosides, and intermediates occurring therein |
| 07/06/1993 | US5225529 Synthetic amphiphilic glycoconjugates for neurological use |
| 07/06/1993 | US5225446 Use of 1-deprenyl for retention of specific physiological functions |
| 07/06/1993 | US5225445 Phenethanolamine derivatives having β2 -adrenoreceptor selective stimulant action |
| 07/06/1993 | US5225442 Compounds having a naphthalene structure |
| 07/06/1993 | US5225441 Treatment of periodontal disease |
| 07/06/1993 | US5225440 Attenuation of the opioid withdrawal syndrome by inhibitors of nitric oxide synthase |
| 07/06/1993 | US5225438 Aryl derivatives |
| 07/06/1993 | US5225435 Water soluble |
| 07/06/1993 | US5225433 Selective, photosensitivity |
| 07/06/1993 | US5225428 Cyclic-substituted imidazolyl-propenoic acid derivatives |
| 07/06/1993 | US5225426 Thiazolidine-2,4-dione compound and method of treatment of diabetic complications |
| 07/06/1993 | US5225424 Hypotensive |
| 07/06/1993 | US5225422 Pyridine compounds which are useful as leukotriene b4 antagonist |
| 07/06/1993 | US5225420 Use of tetrahydrothienopyridine derivatives as angiogenesis inhibitors |
| 07/06/1993 | US5225416 1,2,3,6-tetrahydropyridine derivatives useful for improving cerebral blood circulation |
| 07/06/1993 | US5225415 4-amidino chroman and 4-amidino pyrano (3,2-c) pyridine derivatives, a process for their preparation and pharmaceutical compositions containing them |
| 07/06/1993 | US5225414 Substituted azoles, a process for their preparation, and their use |
| 07/06/1993 | US5225411 Disubstituted polymethyleneimines |
| 07/06/1993 | US5225410 Triazolyl hydrazide derivatives |
| 07/06/1993 | US5225409 Benzoxazinone compounds |
| 07/06/1993 | US5225408 Biphenyl oxadiazinone angiotensin II inhibitors |
| 07/06/1993 | US5225407 5-HT3 receptor antagonists for the treatment of autism |
| 07/06/1993 | US5225405 Use of triazine and pyrimidine compounds for obtaining medicaments that reverse resistance to anti-cancer and anti-malarial agents |
| 07/06/1993 | US5225404 Methods of treating colon tumors with tumor-inhibiting camptothecin compounds |
| 07/06/1993 | US5225403 C-21 hydroxylated FK-506 antagonist |
| 07/06/1993 | US5225401 Endopeptidase inhibitors for congestive heart failure |
| 07/06/1993 | US5225338 Microbial preparation of 13β-13-deoxy-22,23-dihydro avermectin-B1A/B1B aglycone |
| 07/06/1993 | US5225330 Detection of Mycoplasma by adding labels by bonding |
| 07/06/1993 | US5225238 Method for coating active principles with a ph-sensitive polymer |
| 07/06/1993 | US5225206 Sustained-release pranoprofen preparation |
| 07/06/1993 | US5225201 Salsalate tablet |
| 07/06/1993 | US5225200 Covering an area with polydimethylsiloxane |
| 07/06/1993 | US5225198 Drug delivery |
| 07/06/1993 | US5225184 Medicaments |
| 07/06/1993 | CA1319932C 2'-alkylidenepyrimidine nucleoside derivatives, process for production thereof, and uses thereof |
| 07/06/1993 | CA1319931C Antiviral antitumor antimetastatic immune system enhancing nucleosides and nucleotides |
| 07/06/1993 | CA1319888C Process for the preparation of an antipsoriatic pharmaceutical composition |
| 07/06/1993 | CA1319887C Non-steroidal anti-inflammatory compositions protected against gastro-intestinal injury with a combination of certain h _and h _receptor blockers |
| 07/06/1993 | CA1319886C Mixed micelle solutions |
| 07/01/1993 | DE4137093A1 Use of avarol as an antioxidant - in the treatment of auto-immune diseases, dermatitis, psoriasis, rheumatic disorders etc. |
| 07/01/1993 | CA2086566A1 Inhibitor for absorption of digested and decomposed products of food and drink |
| 07/01/1993 | CA2086442A1 N-acyl derivatives of aminoalcohols active as local autocoidis and useful in the therapy of autoimmune processes |
| 07/01/1993 | CA2086441A1 N-acyl derivatives of aminoalcohols with polycarboxylic acids able to modulate mast cells in inflammatory processes having meuroimmunogenic origin |
| 07/01/1993 | CA2086357A1 N-[3-[2-(1h-imidazol-1-yl) ethoxy]phenyl]-4-(2-thienyl) -2-pyrimidinamine and pharmacologically acceptable salts |
| 07/01/1993 | CA2086348A1 2-saccharinylmethyl aryl and aryloxy acetates useful as proteolytic enzyme inhibitors and compositions and method of use thereof |
| 07/01/1993 | CA2086346A1 2-saccharinylmethyl heterocyclic carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use thereof |
| 07/01/1993 | CA2085956A1 Oral hygiene compositions containing amino sugars as antiplaque agents |
| 07/01/1993 | CA2085955A1 Oral hygiene compositions containing antiplaque agents |
| 06/30/1993 | EP0549441A1 Juvenile hormone agents for systemically treating ectoparasites |
| 06/30/1993 | EP0549433A1 Use of N'-substituted N-phenylsulfonylureas in the treatment of hypertension in insulin-resistant patients |
| 06/30/1993 | EP0549407A1 Novel pyrrolidine derivatives, process for their preparation and pharmaceutical compositions containing them |
| 06/30/1993 | EP0549367A1 Method of treating milk fever disease in dairy cattle |
| 06/30/1993 | EP0549366A1 Thiazolidine compounds containing a quinone group, their preparation and their therapeutic uses |
| 06/30/1993 | EP0549365A1 Thiazolidine compounds, their preparation and their therapeutic uses |
| 06/30/1993 | EP0549364A1 Pyridylthiazolidinecarboxylic acid amide derivatives, their preparation and their therapeutic uses |
| 06/30/1993 | EP0549348A1 Arylidene-heterocyclic derivatives, process for their preparation and their use as tyrisine kinase inhibitors |
| 06/30/1993 | EP0549331A1 Controlled release drug dispersion delivery device |
| 06/30/1993 | EP0549318A2 26,27-Dimethylene-1 alpha, 25-dihydroxyvitamin D2 and 26,27-dihydroxyvitamin D2 and methods for preparing same |
| 06/30/1993 | EP0549281A1 Dentinal desensitizing compositions |
| 06/30/1993 | EP0549267A1 Lip treatment composition |
| 06/30/1993 | EP0549073A1 Novel 2-saccharinylmethyl and 4,5,6,7-tetrahydro-2-saccharinylmethyl phosphates, phosphonates and phosphinates useful as proteolytic enzyme inhibitors and compositions and method of use thereof |
| 06/30/1993 | EP0549041A1 17-Spirofuran-3'-ylidene steroids |
| 06/30/1993 | EP0549040A1 Methods of making 4" derivatives of 9-deoxo-8a-aza-8a-alkyl-8a-homoerythromycin A |
| 06/30/1993 | EP0549039A1 3-Phenylureido-1,4-Benzodiazepinones and their use as cholecystokinin or gastrin antagonists |
| 06/30/1993 | EP0548949A2 Fused benzeneoxyacetic acid derivatives |
| 06/30/1993 | EP0548947A1 Optically active fluorine-containing compounds |
| 06/30/1993 | EP0548884A1 Biphosphonate derivative |
| 06/30/1993 | EP0548883A1 Substituted pyridine-N-oxides, process for their preparation and their use as medicines |
| 06/30/1993 | EP0548834A1 Stable hexahydrate of etoposide 4'-phosphate disodium salt |
| 06/30/1993 | EP0548824A1 Novel tricyclic steroid analogs |
| 06/30/1993 | EP0548813A1 Antimigraine 4-pyrimidinyl and pyridinyl derivatives of indol-3yl-alkyl piperazines |
| 06/30/1993 | EP0548798A1 Antiviral agent |
| 06/30/1993 | EP0548793A2 Ethylenic-unsaturated bile acid derivatives, process for their production and preliminary processes therefor |